For the year ending 2025-12-31, COCP has $9,712K in assets. $3,381K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 7,025 | |||
| Restricted cash | 75 | |||
| Tax credit receivable | 706 | |||
| Prepaid expenses and other current assets | 328 | |||
| Total current assets | 8,134 | |||
| Total property and equipment | 2,094 | |||
| Less accumulated depreciation | 2,001 | |||
| Property and equipment, net | 93 | |||
| Deposits | 95 | |||
| Operating lease right of use assets related party | 1,390 | |||
| Total assets | 9,712 | |||
| Accounts payable and accrued expenses | 1,876 | |||
| Operating lease liabilities related party current | 334 | |||
| Total current liabilities | 2,210 | |||
| Operating lease liabilities related party non-current | 1,171 | |||
| Total long-term liabilities | 1,171 | |||
| Total liabilities | 3,381 | |||
| Common stock 0.001 par value 100,000 and 150,000 shares authorized as of december 31, 2025 and 2024, respectively 13,784 and 10,174 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 13 | |||
| Additional paid-in capital | 348,567 | |||
| Accumulated deficit | -342,249 | |||
| Total stockholders equity | 6,331 | |||
| Total liabilities and stockholders equity | 9,712 | |||
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP)